Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 4951 - 4975 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Other Neutral glycosphingolipids LMSP05000001
  • N-(34S-methyl-5Z,9Z,12Z,15Z,18Z,21Z-hexatriacontahexaenoyl)-1-sulfo-beta-D-fucosyl-(16R-methyl-sphing-4-enine)
  • Syriacin
52931241 1059.777221 C62H109NO10S
Gangliosides LMSP0601BC07
  • GalNAc-GM1(d18:1/24:1(15Z))
  • GalNAcbeta1-4Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262194 1831.034286 C87H154N4O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CO04
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261495 2365.213891 C106H188N4O53
Gangliosides LMSP0601EC05
  • KDN(2-6)lactotetraosylceramide(d18:1/24:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262768 1588.944013 C77H140N2O31
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BK07
  • Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260458 1498.912318 C74H134N2O28
Gangliosides LMSP0601GT06
  • NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44263273 2388.26626 C109H193N5O51
Ascarosides LMFA13040099
  • 1-O-(13R-(3,6-dideoxy-alpha-L-arabino-hexopyranosyloxy)-tetradecanoyl)-beta-D-glucopyranose
  • glas#24
86289881 79306 536.319665 C26H48O11
Gangliosides LMSP0601FX06
  • NeuAcalpha2-3GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44263113 1861.081236 C89H160N4O36
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AJ03
  • Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260558 1444.865368 C70H128N2O28
Simple Glc series LMSP05010155
  • Flavuside A
  • N-(2R-hydroxy-octadecanoyl)-1-beta-glucosyl-10-methyl-sphinga-4E,9E-dienine
755.591134 C43H81NO9
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505EB03
  • Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261742 2467.245586 C110H194N4O56
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AG06
  • Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260217 1894.091467 C90H163N3O38
Simple Glc series LMSP05010031
  • 1-beta-glucosyl-sphing-4-enine
  • Glucosyl sphingosine
C03108 5280570 71981 461.335254 C24H47NO7
Monoacylglycerophosphoinositolglycans LMGP15040003
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM1(18:0/0:0)
126457660 762.380293 C33H63O17P
LMSL03000451
  • 2-O-hexadecanoyl-3-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-6-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-docosenoyl)-4'-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-alpha,alpha-trehalose
  • PAT16(26:1(2E)(2Me,4Me[S],6Me[S])/25:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S])/24:0(2Me[R],3OH[R],4Me[S],6Me[S]))
52930288 2173.916755 C137H256O17
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA00
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AE02
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type II B antigen(d18:1/18:0)
44261005 1562.891978 C74H134N2O32
Diacylglycerophosphoinositolglycans LMGP15010006
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/18:0)
126457374 1000.609958 C49H93O18P
Ascarosides LMFA13040148
  • 8R-(3,6-dideoxy-(4-O-hydroxybenzoyl)alpha-L-arabino-hexopyranosyloxy)-nonanoic acid
  • hbas#10
86289886 79330 424.20972 C22H32O8
LMSL03000141
  • 2-O-hexadecanoyl-3-O-(2,4S,6S-trimethyl-2E-docosenoyl)-6-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-2'-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-4'-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-alpha,alpha-trehalose
  • PAT16(22:1(2E)(2Me,4Me[S],6Me[S])/24:0(2Me[R],3OH[R],4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S])/24:0(2Me[R],3OH[R],4Me[S],6Me[S]))
52929978 2177.91167 C136H256O18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AS07
  • Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • iGb5(d18:1/24:1(15Z))
44261586 1498.912318 C74H134N2O28
Diacylglycerophosphoinositolglycans LMGP15010033
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/16:0)
126457401 1014.625608 C50H95O18P
Gangliosides LMSP0601FW03
  • NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • X4 ganglioside(d18:1/20:0)
44263102 2742.34609 C121H211N5O63
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CO07
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261498 2391.229541 C108H190N4O53
LMSL03001176
  • 2-octadecanoyl-3-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-6-O-(2,4S,6S-trimethyl-2E-tetracosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-docosenoyl)-4'-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-alpha,alpha-trehalose
  • PAT18(24:0(2Me[R],3OH[R],4Me[S],6Me[S])/24:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S])/24:0(2Me[R],3OH[R],4Me[S],6Me[S]))
52931013 2177.91167 C136H256O18

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024